Table of Contents United States Bronchopulmonary Dysplasia Drug Market Report 2017 1 Bronchopulmonary Dysplasia Drug Overview 1.1 Product Overview and Scope of Bronchopulmonary Dysplasia Drug 1.2 Classification of Bronchopulmonary Dysplasia Drug by Product Category 1.2.1 United States Bronchopulmonary Dysplasia Drug Market Size (Sales Volume) Comparison by Type (2012-2022) 1.2.2 United States Bronchopulmonary Dysplasia Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 Budesonide 1.2.4 Caffeine Citrate 1.2.5 CG-100 1.2.6 Others 1.3 United States Bronchopulmonary Dysplasia Drug Market by Application/End Users 1.3.1 United States Bronchopulmonary Dysplasia Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 United States Bronchopulmonary Dysplasia Drug Market by Region 1.4.1 United States Bronchopulmonary Dysplasia Drug Market Size (Value) Comparison by Region (2012-2022) 1.4.2 The West Bronchopulmonary Dysplasia Drug Status and Prospect (2012-2022) 1.4.3 Southwest Bronchopulmonary Dysplasia Drug Status and Prospect (2012-2022) 1.4.4 The Middle Atlantic Bronchopulmonary Dysplasia Drug Status and Prospect (2012-2022) 1.4.5 New England Bronchopulmonary Dysplasia Drug Status and Prospect (2012-2022) 1.4.6 The South Bronchopulmonary Dysplasia Drug Status and Prospect (2012-2022) 1.4.7 The Midwest Bronchopulmonary Dysplasia Drug Status and Prospect (2012-2022) 1.5 United States Market Size (Value and Volume) of Bronchopulmonary Dysplasia Drug (2012-2022) 1.5.1 United States Bronchopulmonary Dysplasia Drug Sales and Growth Rate (2012-2022) 1.5.2 United States Bronchopulmonary Dysplasia Drug Revenue and Growth Rate (2012-2022) 2 United States Bronchopulmonary Dysplasia Drug Market Competition by Players/Suppliers 2.1 United States Bronchopulmonary Dysplasia Drug Sales and Market Share of Key Players/Suppliers (2012-2017) 2.2 United States Bronchopulmonary Dysplasia Drug Revenue and Share by Players/Suppliers (2012-2017) 2.3 United States Bronchopulmonary Dysplasia Drug Average Price by Players/Suppliers (2012-2017) 2.4 United States Bronchopulmonary Dysplasia Drug Market Competitive Situation and Trends 2.4.1 United States Bronchopulmonary Dysplasia Drug Market Concentration Rate 2.4.2 United States Bronchopulmonary Dysplasia Drug Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Bronchopulmonary Dysplasia Drug Manufacturing Base Distribution, Sales Area, Product Type 3 United States Bronchopulmonary Dysplasia Drug Sales (Volume) and Revenue (Value) by Region (2012-2017) 3.1 United States Bronchopulmonary Dysplasia Drug Sales

List of Tables and Figures Figure Product Picture of Bronchopulmonary Dysplasia Drug Figure United States Bronchopulmonary Dysplasia Drug Market Size (K Pcs) by Type (2012-2022) Figure United States Bronchopulmonary Dysplasia Drug Sales Volume Market Share by Type (Product Category) in 2016 Figure Budesonide Product Picture Figure Caffeine Citrate Product Picture Figure CG-100 Product Picture Figure Others Product Picture Figure United States Bronchopulmonary Dysplasia Drug Market Size (K Pcs) by Application (2012-2022) Figure United States Sales Market Share of Bronchopulmonary Dysplasia Drug by Application in 2016 Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Others Examples Table Key Downstream Customer in Others Figure United States Bronchopulmonary Dysplasia Drug Market Size (Million USD) by Region (2012-2022) Figure The West Bronchopulmonary Dysplasia Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Southwest Bronchopulmonary Dysplasia Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The Middle Atlantic Bronchopulmonary Dysplasia Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure New England Bronchopulmonary Dysplasia Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The South of US Bronchopulmonary Dysplasia Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The Midwest Bronchopulmonary Dysplasia Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Bronchopulmonary Dysplasia Drug Sales (K Pcs) and Growth Rate (2012-2022) Figure United States Bronchopulmonary Dysplasia Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Bronchopulmonary Dysplasia Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017) Table United States Bronchopulmonary Dysplasia Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017) Table United States Bronchopulmonary Dysplasia Drug Sales Share by Players/Suppliers (2012-2017) Figure 2016 United States Bronchopulmonary Dysplasia Drug Sales Share by Players/Suppliers Figure 2017 United States Bronchopulmonary Dysplasia Drug Sales Share by Players/Suppliers Figure United States Bronchopulmonary Dysplasia Drug Market Major Players Product Revenue (Million USD) (2012-2017) Table United States Bronchopulmonary Dysplasia Drug Revenue (Million USD) by Players/Suppliers (2012-2017) Table United States Bronchopulmonary Dysplasia Drug Revenue Share by Players/Suppliers (2012-2017) Figure 2016 United States Bronchopulmonary Dysplasia Drug Revenue Share by Players/Suppliers Figure 2017 United States Bronchopulmonary Dysplasia Drug Revenue Share by Players/Suppliers Table United States Market Bronchopulmonary Dysplasia Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017) F